Neumora Therapeutics Names Henry Gosebruch as President and Chief Executive Officer
Read More
Archive for Press Releases
Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder
Read More
Neumora Expands Precision Neuroscience Pipeline with Novel M4 Receptor Modulator Program Through Exclusive License Agreement with Vanderbilt University
Read More
Neumora Therapeutics Launches to Pioneer a New Era of Precision Medicines for Brain Diseases
Read More
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
Read More